Health Catalyst
HCAT

$7.29

1.22%

Market Cap: $441M

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,300

Information Technology Computer Programming, Data Processing, Etc.

0

Funds holding %

of 6,686 funds

0

Analysts bullish %

of 6 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

133,617% more call options, than puts

Call options by funds: $16M | Put options by funds: $12K

23% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 52

0% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]

0% more ownership

Funds ownership: 86.35% [Q1] → 86.35% (+0%) [Q2]

8% less funds holding

Funds holding: 172 [Q1] → 159 (-13) [Q2]

14% less capital invested

Capital invested by funds: $380M [Q1] → $325M (-$55.1M) [Q2]

33% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 40

See Fund Rankings

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$7

4%

downside

Avg. target

$11.83

62%

upside

High target

$16

119%

upside

6 analyst ratings

5 positive

83%

1 neutral

17%

0 negative

0%

JP Morgan Anne Samuel 40% 1-year accuracy 2 / 5 met price target	78%upside $13	Overweight Maintained	4 Sept 2024
Piper Sandler Jessica Tassan 50% 1-year accuracy 9 / 18 met price target	51%upside $11	Overweight Maintained	26 Aug 2024
Cantor Fitzgerald Sarah James 67% 1-year accuracy 84 / 125 met price target	119%upside $16	Overweight Reiterated	20 Aug 2024
Cantor Fitzgerald Sarah James 67% 1-year accuracy 84 / 125 met price target	119%upside $16	Overweight Reiterated	9 Aug 2024
Stephens & Co. Jeff Garro 60% 1-year accuracy 3 / 5 met price target	4%downside $7	Equal-Weight Maintained	8 Aug 2024

See Analyst Rankings

Financial journalist opinion

Health Catalyst to Participate in Upcoming Investor Conferences

SALT LAKE CITY, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:

Health Catalyst to Participate in Upcoming Investor Conferences

WISHIN Expands Relationship with Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite

SALT LAKE CITY , Aug. 27, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Wisconsin Statewide Health Information Network, Inc. (WISHIN), an independent not-for-profit organization dedicated to bringing the benefits of widespread, secure, interoperable health information technology to patients and caregivers throughout Wisconsin, has selected to expand its multi-year agreement with Health Catalyst. The multi-year arrangement will include migrating technology and services to Health Catalyst's Ninja Universe™ Suite, an end-to-end cloud-native platform, and a set of applications purpose-built for Health Information Exchanges (HIEs).

WISHIN Expands Relationship with Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite

Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon

SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. and United Kingdom dedicated to helping provider organizations mend broken care coordination processes through automated care orchestration. Leading providers in the U.S. and the United Kingdom use Lumeon's Care Orchestration technology to lower costs, optimize clinician and staff time, enhance revenue, and improve quality and patient safety.

Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon

Health Catalyst and South Dakota Health Link Expand Partnership to Improve the Quality and Effectiveness of Healthcare in the Midwest

SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded relationship with longtime client, South Dakota Health Link ("Health Link"). This renewed agreement will include an expansion of technology and services, including the migration of technology to Ninja Universe by Health Catalyst™, an end-to-end cloud-native platform and set of applications purpose-built for Health Information Exchanges (HIEs).

Health Catalyst and South Dakota Health Link Expand Partnership to Improve the Quality and Effectiveness of Healthcare in the Midwest

Health Catalyst Announces Partnership Expansion with Western U.S.'s Largest Health Information Exchange, Contexture

SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded partnership with Contexture, a nonprofit, regional health information exchange organization that works to drive health data interoperability. Contexture supports the flow of health information between thousands of physician practices, hospitals, long-term care facilities, labs, radiology centers, and other healthcare organizations in Arizona and Colorado.

Health Catalyst Announces Partnership Expansion with Western U.S.'s Largest Health Information Exchange, Contexture

Health Catalyst, Inc. (HCAT) Q2 2024 Earnings Call Transcript

Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Jack Knight - VP, IR Dan Burton - CEO & Director Dan LeSueur - COO Jason Alger - CFO Conference Call Participants Stephanie Davis - Barclays Anne Samuel - JPMorgan Jared Haase - William Blair Sameer Patel - Evercore ISI Richard Close - Canaccord Genuity John Ransom - Raymond James Jessica Tassan - Piper Sandler Jenny Shen - BTIG Jack Wallace - Guggenheim Securities Stan Berenshteyn - Wells Fargo Jeff Garro - Stephens Operator Welcome to the Health Catalyst Second Quarter 2024 Earnings Conference Call. At this time all participants have been placed on a listen-only mode, and the floor will be open for your questions, following the presentation.

Health Catalyst, Inc. (HCAT) Q2 2024 Earnings Call Transcript

Zacks Investment Research

Health Catalyst (HCAT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Health Catalyst (HCAT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research

Health Catalyst (HCAT) Tops Q2 Earnings and Revenue Estimates

Health Catalyst (HCAT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago.

Health Catalyst (HCAT) Tops Q2 Earnings and Revenue Estimates

Health Catalyst Reports Second Quarter 2024 Results

SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2024.

Health Catalyst Reports Second Quarter 2024 Results

Health Catalyst Announces New Credit Facility for up to $225,000,000

SALT LAKE CITY , July 18, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has entered into a five-year term loan facility for up to $225,000,000 (the "Credit Facility" or the "Financing") with Silver Point Finance, the direct lending business of Silver Point Capital, L.P. The Financing consists of (i) an initial term loan facility in an aggregate principal amount of $125,000,000 (the "Initial Facility") and (ii) a delayed draw term loan facility (the "Delayed Draw Facility") in an aggregate principal amount of $100,000,000.

Health Catalyst Announces New Credit Facility for up to $225,000,000

See News Rankings